Submitted for Publication: October 10, 2012; final revision received March 12, 2013; accepted March 13, 2013.
Published Online: October 30, 2013. doi:10.1001/jamapsychiatry.2013.2105.
Study concept and design: All authors.
Acquisition of data: Iltis, Misra, Glowinski, DuBois.
Analysis and interpretation of data: Iltis, Misra, Glowinski, DuBois.
Drafting of the manuscript: Iltis, Misra, Dunn, Glowinski, Hadley, DuBois.
Critical revision of the manuscript for important intellectual content: Iltis, Misra, Dunn, Brown, Campbell, Earll, Glowinski, Pies, DuBois.
Obtained funding: DuBois.
Administrative, technical, and material support: Iltis, Misra, Brown, Hadley, DuBois.
Study supervision: Iltis, Misra, DuBois.
Conflict of Interest Disclosures: Dr Dunn reports serving as a consultant in 2012 to Eli Lilly Inc. No other disclosures were reported.
Funding/Support: This work was supported by the National Institute of Mental Health (grant 1R13MH079690) and the National Center for Advancing Translational Science (grant UL1 TR000448), National Institutes of Health.
Role of the Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.